New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ARUN;TSN;WMGI;LOW;CSCO;BMTI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 28, 2014
06:38 EDTWMGIWright Medical downgraded to Buy from Strong Buy at Needham
Subscribe for More Information
06:24 EDTWMGIWright Medical upgraded to Outperform from Sector Perform at RBC Capital
05:32 EDTWMGITornier downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Tornier (TRNX) to Market Perform citing the merger deal with Wright Medical (WMGI). Wells sees a low likelihood of another suitor emerging.
October 27, 2014
18:26 EDTWMGIOn The Fly: After Hours Movers
Subscribe for More Information
16:29 EDTWMGIWright Medical sees Tornier deal accretive to adjusted EBITDA in second year
Subscribe for More Information
16:29 EDTWMGIWright Medical to acquire Tornier in all-stock deal, own 52% of combined company
Subscribe for More Information
16:25 EDTWMGIWright Medical announces receipt of FDA approvable letter for Augment bone graft
Wright Medical Group announced that its BioMimetic subsidiary has received an Approvable Letter from the FDA for its Premarket Approval Application for Augment Bone Graft. The approvable letter indicates that FDA determined Augment Bone Graft to be safe and effective as an alternative to autograft for ankle and/or hindfoot fusion indications and is approvable subject to customary preapproval facilities inspections. Robert Palmisano, president and CEO of Wright Medical, stated, “Today’s positive news on the approvability of Augment Bone Graft is a major milestone that paves the way for commercialization in the U.S. and further underscores our strength in Biologics. Augment will provide clear benefits to patients and physicians and is expected to be a significant catalyst and meaningful new future growth driver for our business. We will work swiftly to address the inspection requirements set forth in the approvable letter and expect our U.S. foot and ankle commercial team to be ready to launch immediately upon final approval.” The company will work with the FDA to coordinate any preapproval inspections. Assuming satisfactory completion of this activity and receipt of a final approval order from the FDA, commercial sale and distribution of Augment Bone Graft can begin in the U.S.
16:19 EDTWMGIWright Medical, Tornier agree to merge in $3.3B transaction
Subscribe for More Information
07:38 EDTCSCOCyber security start-ups hot with investors, including banks, FT says
Corporate venture arms have more than doubled their investment in cyber security start-ups over the last two years, according to Financial Times, citing data from CB Insights. While technology companies such as Google (GOOG), Intel (INTC) and Cisco (CSCO) are leading, the report notes that the venture capital units of Citibank (C), Wells Fargo (WFC) and General Electric (GE) have also been active investors in security start-ups. Reference Link
07:30 EDTCSCOInternational Economic Forum of the Americas to hold a forum
Subscribe for More Information
October 24, 2014
11:25 EDTCSCOJuniper falls after Q4 profit outlook trails consensus
Subscribe for More Information
October 22, 2014
11:25 EDTCSCOCisco sale of VCE stake to have limited impact, says Wells Fargo
Wells Fargo thinks Cisco's (CSCO) decision to sell a portion of its stake in VCE is unlikely to have a material near-to-intermediate-term impact on the company's top line since it will continue to sell its networking and compute solutions to the joint venture. Wells says Cisco's "budding" partnerships with NetApp (NTAP), Microsoft (MSFT) and Citrix (CTXS) should more than offset any potential impacts from lessening ties to EMC (EMC) and VMware (VMW).
08:18 EDTCSCOVCE to become an EMC company
Subscribe for More Information
October 21, 2014
20:00 EDTCSCOEMC said to buy out most of Cisco VCE joint venture stake, Bloomberg reports
Subscribe for More Information
14:34 EDTCSCOEarnings Preview: EMC reports after HPQ merger talks said to end
EMC Corporation (EMC) is expected to report third quarter earnings before the bell on Wednesday, October 22, with a conference call scheduled for 8:30 am ET. EMC provides software, hardware and IT services to business customers through its three federated businesses: EMC Information Infrastructure, Pivotal and VMware Virtual Infrastructure, which is represented by EMC’s majority equity stake in VMware (VMW). VMware is expected to report on its own third quarter results after the bell on Tuesday, October 21, with a conference call scheduled for 5:00 pm ET. EXPECTATIONS: For EMC, analysts are looking for earnings per share of 46c on revenue of $6.0B. The consensus range is 44c-49c for EPS and $5.91B-$6.16B for revenue, according to First Call. Along with its last earnings report, EMC raised its FY14 adjusted EPS view to $1.91 from $1.90 and guided to FY14 revenues of $24.58B. Analysts consensus for FY14 EPS and revenue currently stand at $1.91 and $24.55B. For VMware, analysts are looking for earnings per share of 83c on revenue of $1.5B. The consensus range is 81c-85c for EPS and $1.48B-$1.52B for revenue, according to First Call. LAST QUARTER: EMC reported Q2 adjusted EPS of 43c, which matched the consensus expectation. EMC's revenue of $5.9B came in slightly ahead of the $5.83B consensus projection. EMC also accelerated its 2014 share buyback plan, stating that it now expects to repurchase an aggregate of $3B of the company's common stock in 2014. VMware reported Q2 EPS of 81c, versus consensus of 79c, on revenue $1.46B, versus consensus of $1.44B. NEWS: VMware held its "VMWorld 2014" conference from August 24-28, during which the company updated its 2015 guidance. VMware's guidance for revenue growth in the mid teens percentage level and margin expansion of up to one percentage point is positive, RBC Capital analyst Matthew Hedberg wrote in a note to investors on August 26. The same day Cowen analyst Gregg Moskowitz wrote that VMware's FY15 revenue guidance would "likely weigh modestly" on the stock, even though he was not surprised by the outlook. Less than two weeks ago, Elliott Management sent a letter to the board of directors of EMC Corporation detailing its recommendations on the right path forward for EMC, in which Elliott holds a stake. Elliott believes that EMC’s Federation structure obscures enormous value at the company and that the board and management should pursue pathways to recognize this value, including a separation of VMware from Core EMC and/or various M&A opportunities, Elliott wrote. In response, EMC said its directors regularly review and evaluate the company's strategy with a view towards enhancing shareholder value. "Over the past few months, EMC's leadership has met with representatives of Elliott several times and has listened carefully to their ideas, as we do with all of our shareholders," the company said. Last week, HP (HPQ) announced the resumption of its share repurchase program after Reuters reported the company's merger talks with EMC had ended. HP had suspended the buyback program due to "possession of material non-public information." The tech giant said that day that it is "no longer in possession of such information." During September, Re/code reported, citing sources familiar with Oracle's plans, that the company was not interested in acquiring EMC. Meanwhile, Cisco (CSCO) CEO John Chambers also said last month at a Wall Street Journal breakfast that his company is not among the potential merger partners for EMC. Chambers said a deal between the two companies would have been done a "year or two ago" were it to happen, according to Reuters. STREET RESEARCH: On the day after its last earnings report, Brean Capital raised its price target on EMC to $33 from $30, citing the company's aggressive capital return strategy, encouraging core Storage dynamics and potential pent up demand. Tigress Financial, however, downgraded EMC to Buy from Strong Buy, citing valuation. Additionally, VMware estimated that its total available market would reach more than $60B in 2017, versus its estimate last year of a $50B+ total addressable market by 2016, Moskowitz noted. PRICE ACTION: In afternoon trading, EMC shares are up 1% to $27.22, while VMware is fractionally higher at $87.79. Over the last three months, EMC shares have declined almost 4%, while VMware's stock is down about 5.5% in that same time frame.
October 17, 2014
09:31 EDTCSCOCisco namnes Bernadette Wightman President of Cisco Cananda
Subscribe for More Information
09:07 EDTTSNProtein stock pullback on Sanderson comments overdone, says BMO Capital
BMO Capital views yesterday's decline in Sanderson Farms (SAFM), Pilgrim's Pride (PPC) and Tyson Foods (TSN) as an overreaction to Sanderson's comments regarding breast prices falling to year-ago levels for the next four months. BMO notes that breast prices always dip in the fall. Following Sanderson's investor day, BMO said it sees a greater probability of chicken margins remaining at near-record levels in 2015. It keeps an Outperform rating on the stock.
08:06 EDTCSCOCisco, Sensity Systems announce strategic relationship
Subscribe for More Information
07:39 EDTTSNChicken stock sell-off yesterday overdone, says JPMorgan
Subscribe for More Information
07:31 EDTWMGIWright Medical risk/reward positive into FDA decision, says JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use